In our study, we employed two different approaches, IF and subcellular fractionation followed by western blot, to confirm the subcellular localization of PAI-1 to the nucleus and the cytoplasm in a subset of bladder cancer patients (Fig 1A–J). Here, SERPINE1 is linked to urinary bladder cancer.